microRNA-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation, and cell proliferation

[1]  Bo Yang,et al.  Gαi3 nuclear translocation causes irradiation resistance in human glioma cells , 2017, Oncotarget.

[2]  H. Yi,et al.  miR-135b expression downregulates Ppm1e to activate AMPK signaling and protect osteoblastic cells from dexamethasone , 2016, Oncotarget.

[3]  Q. Jiang,et al.  SC79 protects retinal pigment epithelium cells from UV radiation via activating Akt-Nrf2 signaling , 2016, Oncotarget.

[4]  Su-qing Yang,et al.  3H-1,2-dithiole-3-thione protects retinal pigment epithelium cells against Ultra-violet radiation via activation of Akt-mTORC1-dependent Nrf2-HO-1 signaling , 2016, Scientific Reports.

[5]  Liu Cao,et al.  PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma , 2016, Oncotarget.

[6]  Qing Xu,et al.  Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells , 2015, Bioscience reports.

[7]  Yuyuan Han,et al.  Gαi1 and Gαi3 regulate macrophage polarization by forming a complex containing CD14 and Gab1 , 2015, Proceedings of the National Academy of Sciences.

[8]  S. Cai,et al.  Over-expression of Gαi3 in human glioma is required for Akt-mTOR activation and cell growth , 2014 .

[9]  M. Kool,et al.  The G-protein Alpha Subunit Gsα Is A Tumor Suppressor In Sonic Hedgehog-driven Medulloblastoma , 2014, Nature Medicine.

[10]  Jin Yao,et al.  Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling. , 2014, Free radical biology & medicine.

[11]  L. Birnbaumer,et al.  Giα proteins exhibit functional differences in the activation of ERK1/2, Akt and mTORC1 by growth factors in normal and breast cancer cells , 2014, Cell Communication and Signaling.

[12]  Tao Jiang,et al.  Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. , 2013, Cancer letters.

[13]  M. Rioult-Pedotti,et al.  Impairment of TrkB-PSD-95 Signaling in Angelman Syndrome , 2013, PLoS biology.

[14]  Aaron S. Gajadhar,et al.  Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. , 2012, The Journal of clinical investigation.

[15]  Rebecca A Betensky,et al.  Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. , 2011, Cancer cell.

[16]  Manfred Westphal,et al.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches , 2011, Nature Reviews Neuroscience.

[17]  G. Velasco,et al.  The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK , 2011, Oncogene.

[18]  I. Pollack.  Neuro-oncology: Therapeutic benefits of reirradiation for recurrent brain tumors , 2010, Nature Reviews Neurology.

[19]  P. Majumder,et al.  MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo , 2010, Molecular Cancer Therapeutics.

[20]  A. Lassman,et al.  Neuro-oncology: Late neurocognitive decline after radiotherapy for low-grade glioma , 2009, Nature Reviews Neurology.

[21]  T. Cloughesy,et al.  Targeted therapy for malignant glioma patients: Lessons learned and the road ahead , 2009, Neurotherapeutics.

[22]  G. McKhann,et al.  Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease , 2008, Nature Medicine.

[23]  Keith L. Ligon,et al.  Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies , 2007, Science.

[24]  R. Ozols,et al.  RAD001 Inhibits Human Ovarian Cancer Cell Proliferation, Enhances Cisplatin-Induced Apoptosis, and Prolongs Survival in an Ovarian Cancer Model , 2007, Clinical Cancer Research.

[25]  D. Sabatini.  mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.

[26]  K. Nikolich,et al.  GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion , 2005, Oncogene.

[27]  M. Mareel,et al.  Suppression of Cellular Invasion by Activated G-Protein Subunits Gαo, Gαi1, Gαi2, and Gαi3 and Sequestration of Gβγ , 2001 .

[28]  Thomas D. Schmittgen,et al.  Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. , 2000, Journal of biochemical and biophysical methods.

[29]  P. Cohen,et al.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.

[30]  G. Hager,et al.  Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus , 1981, Cell.

[31]  K. Shulman,et al.  Cyclic AMP and adenyl cyclase in brain tumors. , 1977, Journal of neurosurgery.

[32]  Q. Jiang,et al.  Requirement of Gαi1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation. , 2015, The Journal of investigative dermatology.

[33]  Wei Zhang,et al.  The anti-ovarian cancer activity by WYE-132, a mTORC1/2 dual inhibitor , 2015, Tumor Biology.

[34]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[35]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[36]  H. Lo.  EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance. , 2010, Current molecular pharmacology.

[37]  R. Kiss,et al.  Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. , 2009, Advances and technical standards in neurosurgery.

[38]  M. Wolter,et al.  Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. , 1998, Cancer research.